deferiprone has been researched along with Carditis in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Deferiprone treatment reduced iron deposition and IR in DC rats except for blood glucose." | 1.46 | Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats. ( Bao, Y; Jia, X; Jin, Q; Li, L; Liu, R; Liu, X; Xie, R; Zou, C, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zou, C | 1 |
| Liu, X | 1 |
| Xie, R | 1 |
| Bao, Y | 1 |
| Jin, Q | 1 |
| Jia, X | 1 |
| Li, L | 1 |
| Liu, R | 1 |
1 other study available for deferiprone and Carditis
| Article | Year |
|---|---|
Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats.
Topics: Animals; Deferiprone; Diabetic Cardiomyopathies; Dose-Response Relationship, Drug; Endomyocardial Fi | 2017 |